Fujirebio, Carna plan kinase alliance
Medical diagnostics company Fujirebio is to combine its microarray platform with Carna Biosciences to create a series of new products for kinase studies.
Medical diagnostics company Fujirebio is to combine its microarray platform with Carna Biosciences to create a series of new products for kinase studies.
Finland's Kemira has completed the divestment of its fine chemicals business, which now operates as KemFine under the control of the division's former management team.
Software manufacturers The Wercs has announced the launch of an automated approval process module to streamline formal chemical requests and approvals for manufacturers using and storing chemicals.
A report that focuses on Alzheimer's Disease and the crop of new drugs to treat it, cites neuroprotection as a potential treatment that may become more effective than the host of symptomatic treatments currently available.
Sigpack Systems has introduced a new packaging line that it claims can achieve a 50 per cent performance increase, using reduced material costs and a return on investment in just six months.
A new study has shown that near-infrared sprectroscopy (NIR) can be used to check the active pharmaceutical ingredient content of tablets - even if they are present in very low quantities - supporting its use in process analytical technology (PAT), a...
Danish pharmaceutical firm Novo Nordisk has launched a new product in its Norditropin range of human growth hormone (hGH) that simplifies the delivery of the drug to children with growing difficulties.